These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26891149)

  • 1. Epigenetic silencing of AKAP12 in juvenile myelomonocytic leukemia.
    Wilhelm T; Lipka DB; Witte T; Wierzbinska JA; Fluhr S; Helf M; Mücke O; Claus R; Konermann C; Nöllke P; Niemeyer CM; Flotho C; Plass C
    Epigenetics; 2016; 11(2):110-9. PubMed ID: 26891149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of the tumor suppressor A-kinase anchor protein 12 in human diffuse and pilocytic astrocytomas is regulated by promoter methylation.
    Goeppert B; Schmidt CR; Geiselhart L; Dutruel C; Capper D; Renner M; Vogel MN; Zachskorn C; Zinke J; Campos B; Schmezer P; Popanda O; Wick W; Weller M; Meyermann R; Schittenhelm J; Harter PN; Simon P; Weichert W; Schirmacher P; Plass C; Mittelbronn M
    J Neuropathol Exp Neurol; 2013 Oct; 72(10):933-41. PubMed ID: 24042196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of tumor suppressor A kinase anchor protein 12 in human hepatocarcinogenesis by epigenetic mechanisms.
    Goeppert B; Schmezer P; Dutruel C; Oakes C; Renner M; Breinig M; Warth A; Vogel MN; Mittelbronn M; Mehrabi A; Gdynia G; Penzel R; Longerich T; Breuhahn K; Popanda O; Plass C; Schirmacher P; Kern MA
    Hepatology; 2010 Dec; 52(6):2023-33. PubMed ID: 20979053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AKAP12, a gene with tumour suppressor properties, is a target of promoter DNA methylation in childhood myeloid malignancies.
    Flotho C; Paulun A; Batz C; Niemeyer CM
    Br J Haematol; 2007 Sep; 138(5):644-50. PubMed ID: 17686059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation of AKAP12{alpha} promoter in lung cancer.
    Jo UH; Whang YM; Sung JS; Kim YH
    Anticancer Res; 2010 Nov; 30(11):4595-600. PubMed ID: 21115911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative assessment of AKAP12 promoter methylation in human prostate cancer using methylation-sensitive high-resolution melting: correlation with Gleason score.
    Liu W; Gong J; Hu J; Hu T; Sun Y; Du J; Sun C; Guan M; Jiang H; Lu Y
    Urology; 2011 Apr; 77(4):1006.e1-7. PubMed ID: 21310466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic dysregulation of the erythropoietic transcription factor KLF1 and the β-like globin locus in juvenile myelomonocytic leukemia.
    Fluhr S; Krombholz CF; Meier A; Epting T; Mücke O; Plass C; Niemeyer CM; Flotho C
    Epigenetics; 2017 Aug; 12(8):715-723. PubMed ID: 28749240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative assessment of AKAP12 promoter methylation in colorectal cancer using methylation-sensitive high resolution melting: Correlation with Duke's stage.
    Liu W; Guan M; Su B; Ye C; Li J; Zhang X; Liu C; Li M; Lin Y; Lu Y
    Cancer Biol Ther; 2010 Jun; 9(11):862-71. PubMed ID: 20364105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid determination of AKAP12 promoter methylation levels in peripheral blood using methylation-sensitive high resolution melting (MS-HRM) analysis: application in colorectal cancer.
    Liu W; Guan M; Su B; Li J; Ma W; Liu C; Li M; Lin Y; Lu Y
    Clin Chim Acta; 2010 Jul; 411(13-14):940-6. PubMed ID: 20227403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RASA4 undergoes DNA hypermethylation in resistant juvenile myelomonocytic leukemia.
    Poetsch AR; Lipka DB; Witte T; Claus R; Nöllke P; Zucknick M; Olk-Batz C; Fluhr S; Dworzak M; De Moerloose B; Starý J; Zecca M; Hasle H; Schmugge M; van den Heuvel-Eibrink MM; Locatelli F; Niemeyer CM; Flotho C; Plass C
    Epigenetics; 2014 Sep; 9(9):1252-60. PubMed ID: 25147919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CREBBP is a target of epigenetic, but not genetic, modification in juvenile myelomonocytic leukemia.
    Fluhr S; Boerries M; Busch H; Symeonidi A; Witte T; Lipka DB; Mücke O; Nöllke P; Krombholz CF; Niemeyer CM; Plass C; Flotho C
    Clin Epigenetics; 2016; 8():50. PubMed ID: 27158276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the A kinase anchor protein 12 (AKAP12) gene as a candidate tumor suppressor of hepatocellular carcinoma.
    Hayashi M; Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Yamada S; Fujii T; Sugimoto H; Takeda S; Kodera Y
    J Surg Oncol; 2012 Mar; 105(4):381-6. PubMed ID: 22052684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia.
    Lipka DB; Witte T; Toth R; Yang J; Wiesenfarth M; Nöllke P; Fischer A; Brocks D; Gu Z; Park J; Strahm B; Wlodarski M; Yoshimi A; Claus R; Lübbert M; Busch H; Boerries M; Hartmann M; Schönung M; Kilik U; Langstein J; Wierzbinska JA; Pabst C; Garg S; Catalá A; De Moerloose B; Dworzak M; Hasle H; Locatelli F; Masetti R; Schmugge M; Smith O; Stary J; Ussowicz M; van den Heuvel-Eibrink MM; Assenov Y; Schlesner M; Niemeyer C; Flotho C; Plass C
    Nat Commun; 2017 Dec; 8(1):2126. PubMed ID: 29259247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examination of AKAP12 promoter methylation in skin cancer using methylation-sensitive high-resolution melting analysis.
    Wu W; Zhang J; Yang H; Shao Y; Yu B
    Clin Exp Dermatol; 2011 Jun; 36(4):381-5. PubMed ID: 21198787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant DNA Methylation Is Associated with a Poor Outcome in Juvenile Myelomonocytic Leukemia.
    Sakaguchi H; Muramatsu H; Okuno Y; Makishima H; Xu Y; Furukawa-Hibi Y; Wang X; Narita A; Yoshida K; Shiraishi Y; Doisaki S; Yoshida N; Hama A; Takahashi Y; Yamada K; Miyano S; Ogawa S; Maciejewski JP; Kojima S
    PLoS One; 2015; 10(12):e0145394. PubMed ID: 26720758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene mutations do not operate in a vacuum: the increasing importance of epigenetics in juvenile myelomonocytic leukemia.
    Flotho C
    Epigenetics; 2019 Mar; 14(3):236-244. PubMed ID: 30773984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 network.
    Caye A; Strullu M; Guidez F; Cassinat B; Gazal S; Fenneteau O; Lainey E; Nouri K; Nakhaei-Rad S; Dvorsky R; Lachenaud J; Pereira S; Vivent J; Verger E; Vidaud D; Galambrun C; Picard C; Petit A; Contet A; Poirée M; Sirvent N; Méchinaud F; Adjaoud D; Paillard C; Nelken B; Reguerre Y; Bertrand Y; Häussinger D; Dalle JH; Ahmadian MR; Baruchel A; Chomienne C; Cavé H
    Nat Genet; 2015 Nov; 47(11):1334-40. PubMed ID: 26457648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple promoters direct expression of three AKAP12 isoforms with distinct subcellular and tissue distribution profiles.
    Streb JW; Kitchen CM; Gelman IH; Miano JM
    J Biol Chem; 2004 Dec; 279(53):56014-23. PubMed ID: 15496411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated molecular profiling of juvenile myelomonocytic leukemia.
    Murakami N; Okuno Y; Yoshida K; Shiraishi Y; Nagae G; Suzuki K; Narita A; Sakaguchi H; Kawashima N; Wang X; Xu Y; Chiba K; Tanaka H; Hama A; Sanada M; Ito M; Hirayama M; Watanabe A; Ueno T; Kojima S; Aburatani H; Mano H; Miyano S; Ogawa S; Takahashi Y; Muramatsu H
    Blood; 2018 Apr; 131(14):1576-1586. PubMed ID: 29437595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International Consensus Definition of DNA Methylation Subgroups in Juvenile Myelomonocytic Leukemia.
    Schönung M; Meyer J; Nöllke P; Olshen AB; Hartmann M; Murakami N; Wakamatsu M; Okuno Y; Plass C; Loh ML; Niemeyer CM; Muramatsu H; Flotho C; Stieglitz E; Lipka DB
    Clin Cancer Res; 2021 Jan; 27(1):158-168. PubMed ID: 33139265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.